Literature DB >> 15765122

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine.

Mitsuru Matsuda1, Yasunari Nakamoto, Satoshi Suzuki, Tomomitsu Kurata, Shuichi Kaneko.   

Abstract

Hepatocarcinogenesis is a complex multifactorial process in which continuous intrahepatic inflammation plays a major role. Although inflammatory cell infiltration is observed in the process of chemical-induced hepatocarcinogenesis, the pathophysiological role of the inflammatory response is not well defined. To approach this question, molecular and cellular responses were monitored during the development of liver tumors in mice exposed to a chemical hepatocarcinogen, diethylnitrosamine (DEN), in drinking water (50 microg/l). Intrahepatic type I and type II interferon (IFN-beta and IFN-gamma, respectively) mRNA expression was found to be induced 2 months before the appearance of hepatocellular carcinomas. The pathogenetic importance of IFNs was determined by monitoring tumor development in mice genetically deficient in the IFN-alpha/beta receptor (IFN-alpha/betaR KO) or the IFN-gamma receptor (IFN-gammaR KO). IFN-gammaR KO mice developed fewer tumors than IFN-alpha/betaR KO and wild-type (wt) mice, although the tumor diameters did not differ significantly among the three lineages. Interestingly, immunohistochemical studies demonstrated that the percentage of monocytes/macrophages in infiltrating mononuclear cells was reduced greatly in the livers of IFN-gammaR KO mice, which is consistent with the facts that intrahepatic cytokine expression was diminished and oxidative DNA damage was induced to a lesser extent. In conclusion, type II IFN, but not type I IFNs, may be involved critically in the initiation stage, but not the promotion stage, of DEN-induced hepatocarcinogenesis by enhancing monocytes/macrophages activation and eventual hepatocyte DNA damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15765122     DOI: 10.1038/labinvest.3700257

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  13 in total

1.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

2.  Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

Authors:  Anna-Maria A De Costa; Corinne A Schuyler; David D Walker; M Rita I Young
Journal:  Cancer Immunol Immunother       Date:  2011-11-25       Impact factor: 6.968

3.  Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition.

Authors:  Johan Tisserand; Konstantin Khetchoumian; Christelle Thibault; Doulaye Dembélé; Pierre Chambon; Régine Losson
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

Review 4.  IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression.

Authors:  Hussein F Aqbi; Matthew Wallace; Samay Sappal; Kyle K Payne; Masoud H Manjili
Journal:  J Leukoc Biol       Date:  2018-02-22       Impact factor: 4.962

5.  Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.

Authors:  M Yeganeh; Y Gui; R Kandhi; D Bobbala; W-S Tobelaim; C Saucier; A Yoshimura; G Ferbeyre; S Ramanathan; S Ilangumaran
Journal:  Oncogene       Date:  2016-01-04       Impact factor: 9.867

6.  IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway.

Authors:  X-Y Shi; X-L Zhang; Q-Y Shi; X Qiu; X-B Wu; B-L Zheng; H-X Jiang; S-Y Qin
Journal:  Clin Transl Oncol       Date:  2022-01-17       Impact factor: 3.405

7.  Different physiology of interferon-α/-γ in models of liver regeneration in the rat.

Authors:  Danko S Batusic; Alexander von Bargen; Sabine Blaschke; Jozsef Dudas; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2011-07-21       Impact factor: 4.304

8.  Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.

Authors:  Faridoddin Mirshahi; Hussein F Aqbi; Madison Isbell; Saeed H Manjili; Chunqing Guo; Mulugeta Saneshaw; Dipankar Bandyopadhyay; Mikhail Dozmorov; Archit Khosla; Katy Wack; Oscar M Carrasco-Zevallos; Michael O Idowu; Xiang-Yang Wang; Arun J Sanyal; Masoud H Manjili
Journal:  Cell Rep       Date:  2022-03-01       Impact factor: 9.995

9.  Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.

Authors:  Katherine S Koch; Hyam L Leffert
Journal:  Hepat Med       Date:  2010-03

10.  Anti-Inflammatory Activity Is a Possible Mechanism by Which the Polyherbal Formulation Comprised of Nigella sativa (Seeds), Hemidesmus indicus (Root), and Smilax glabra (Rhizome) Mediates Its Antihepatocarcinogenic Effects.

Authors:  Prasanna B Galhena; Sameera R Samarakoon; M Ira Thabrew; G A K Weerasinghe; Mayuri G Thammitiyagodage; W D Ratnasooriya; Kamani H Tennekoon
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.